COVID-19 and cardiac arrhythmias: a global perspective on arrhythmia characteristics and management strategies.
Identifieur interne : 001509 ( Main/Corpus ); précédent : 001508; suivant : 001510COVID-19 and cardiac arrhythmias: a global perspective on arrhythmia characteristics and management strategies.
Auteurs : Rakesh Gopinathannair ; Faisal M. Merchant ; Dhanunjaya R. Lakkireddy ; Susan P. Etheridge ; Suzy Feigofsky ; Janet K. Han ; Rajesh Kabra ; Andrea Natale ; Stacy Poe ; Sandeep A. Saha ; Andrea M. RussoSource :
- Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing [ 1572-8595 ] ; 2020.
English descriptors
- KwdEn :
- Anti-Arrhythmia Agents (administration & dosage), Arrhythmias, Cardiac (diagnostic imaging), Arrhythmias, Cardiac (drug therapy), Arrhythmias, Cardiac (epidemiology), COVID-19 (MeSH), Coronavirus Infections (diagnosis), Coronavirus Infections (drug therapy), Coronavirus Infections (epidemiology), Cross-Sectional Studies (MeSH), Electrocardiography (methods), Female (MeSH), Humans (MeSH), Incidence (MeSH), Long QT Syndrome (diagnostic imaging), Long QT Syndrome (drug therapy), Long QT Syndrome (epidemiology), Male (MeSH), Pandemics (prevention & control), Pandemics (statistics & numerical data), Pneumonia, Viral (diagnosis), Pneumonia, Viral (drug therapy), Pneumonia, Viral (epidemiology), Prognosis (MeSH), Severity of Illness Index (MeSH), Surveys and Questionnaires (MeSH), Survival Rate (MeSH), Torsades de Pointes (diagnostic imaging), Torsades de Pointes (drug therapy), Torsades de Pointes (epidemiology), Treatment Outcome (MeSH).
- MESH :
- chemical , administration & dosage : Anti-Arrhythmia Agents.
- diagnosis : Coronavirus Infections, Pneumonia, Viral.
- diagnostic imaging : Arrhythmias, Cardiac, Long QT Syndrome, Torsades de Pointes.
- drug therapy : Arrhythmias, Cardiac, Coronavirus Infections, Long QT Syndrome, Pneumonia, Viral, Torsades de Pointes.
- epidemiology : Arrhythmias, Cardiac, Coronavirus Infections, Long QT Syndrome, Pneumonia, Viral, Torsades de Pointes.
- methods : Electrocardiography.
- prevention & control : Pandemics.
- statistics & numerical data : Pandemics.
- COVID-19, Cross-Sectional Studies, Female, Humans, Incidence, Male, Prognosis, Severity of Illness Index, Surveys and Questionnaires, Survival Rate, Treatment Outcome.
Abstract
BACKGROUND
Cardiovascular and arrhythmic events have been reported in hospitalized COVID-19 patients. However, arrhythmia manifestations and treatment strategies used in these patients have not been well-described. We sought to better understand the cardiac arrhythmic manifestations and treatment strategies in hospitalized COVID-19 patients through a worldwide cross-sectional survey.
METHODS
The Heart Rhythm Society (HRS) sent an online survey (via SurveyMonkey) to electrophysiology (EP) professionals (physicians, scientists, and allied professionals) across the globe. The survey was active from March 27 to April 13, 2020.
RESULTS
A total of 1197 respondents completed the survey with 50% of respondents from outside the USA, representing 76 countries and 6 continents. Of respondents, 905 (76%) reported having COVID-19-positive patients in their hospital. Atrial fibrillation was the most commonly reported tachyarrhythmia whereas severe sinus bradycardia and complete heart block were the most common bradyarrhythmias. Ventricular tachycardia/ventricular fibrillation arrest and pulseless electrical activity were reported by 4.8% and 5.6% of respondents, respectively. There were 140 of 631 (22.2%) respondents who reported using anticoagulation therapy in all COVID-19-positive patients who did not otherwise have an indication. One hundred fifty-five of 498 (31%) reported regular use of hydroxychloroquine/chloroquine (HCQ) + azithromycin (AZM); concomitant use of AZM was more common in the USA. Sixty of 489 respondents (12.3%) reported having to discontinue therapy with HCQ + AZM due to significant QTc prolongation and 20 (4.1%) reported cases of Torsade de Pointes in patients on HCQ/chloroquine and AZM. Amiodarone was the most common antiarrhythmic drug used for ventricular arrhythmia management.
CONCLUSIONS
In this global survey of > 1100 EP professionals regarding hospitalized COVID-19 patients, a variety of arrhythmic manifestations were observed, ranging from benign to potentially life-threatening. Observed adverse events related to use of HCQ + AZM included prolonged QTc requiring drug discontinuation as well as Torsade de Pointes. Large prospective studies to better define arrhythmic manifestations as well as the safety of treatment strategies in COVID-19 patients are warranted.
DOI: 10.1007/s10840-020-00789-9
PubMed: 32494896
PubMed Central: PMC7268965
Links to Exploration step
pubmed:32494896Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">COVID-19 and cardiac arrhythmias: a global perspective on arrhythmia characteristics and management strategies.</title><author><name sortKey="Gopinathannair, Rakesh" sort="Gopinathannair, Rakesh" uniqKey="Gopinathannair R" first="Rakesh" last="Gopinathannair">Rakesh Gopinathannair</name><affiliation><nlm:affiliation>The Kansas City Heart Rhythm Institute & Research Foundation, 5100 W 110th St, Ste 200, Overland Park, KS, 66211, USA. drrakeshg@yahoo.com.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>University of Missouri-Columbia, Columbia, USA. drrakeshg@yahoo.com.</nlm:affiliation></affiliation></author><author><name sortKey="Merchant, Faisal M" sort="Merchant, Faisal M" uniqKey="Merchant F" first="Faisal M" last="Merchant">Faisal M. Merchant</name><affiliation><nlm:affiliation>Emory University School of Medicine, Atlanta, GA, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Lakkireddy, Dhanunjaya R" sort="Lakkireddy, Dhanunjaya R" uniqKey="Lakkireddy D" first="Dhanunjaya R" last="Lakkireddy">Dhanunjaya R. Lakkireddy</name><affiliation><nlm:affiliation>The Kansas City Heart Rhythm Institute & Research Foundation, 5100 W 110th St, Ste 200, Overland Park, KS, 66211, USA.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>University of Missouri-Columbia, Columbia, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Etheridge, Susan P" sort="Etheridge, Susan P" uniqKey="Etheridge S" first="Susan P" last="Etheridge">Susan P. Etheridge</name><affiliation><nlm:affiliation>University of Utah, Salt Lake City, UT, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Feigofsky, Suzy" sort="Feigofsky, Suzy" uniqKey="Feigofsky S" first="Suzy" last="Feigofsky">Suzy Feigofsky</name><affiliation><nlm:affiliation>Iowa Heart Center, Des Moines, IA, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Han, Janet K" sort="Han, Janet K" uniqKey="Han J" first="Janet K" last="Han">Janet K. Han</name><affiliation><nlm:affiliation>Cardiac Arrhythmia Center, University of California at Los Angeles and VA Greater Los Healthcare Center, Los Angeles, CA, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Kabra, Rajesh" sort="Kabra, Rajesh" uniqKey="Kabra R" first="Rajesh" last="Kabra">Rajesh Kabra</name><affiliation><nlm:affiliation>University of Tennessee Health Science Center, Memphis, TN, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Natale, Andrea" sort="Natale, Andrea" uniqKey="Natale A" first="Andrea" last="Natale">Andrea Natale</name><affiliation><nlm:affiliation>Texas Cardiac Arrhythmia Institute, Austin, TX, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Poe, Stacy" sort="Poe, Stacy" uniqKey="Poe S" first="Stacy" last="Poe">Stacy Poe</name><affiliation><nlm:affiliation>Cleveland Clinic, Cleveland, OH, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Saha, Sandeep A" sort="Saha, Sandeep A" uniqKey="Saha S" first="Sandeep A" last="Saha">Sandeep A. Saha</name><affiliation><nlm:affiliation>Oregon Heart Center, Salem, OR, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Russo, Andrea M" sort="Russo, Andrea M" uniqKey="Russo A" first="Andrea M" last="Russo">Andrea M. Russo</name><affiliation><nlm:affiliation>Cooper University Hospital, Camden, NJ, USA.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32494896</idno><idno type="pmid">32494896</idno><idno type="doi">10.1007/s10840-020-00789-9</idno><idno type="pmc">PMC7268965</idno><idno type="wicri:Area/Main/Corpus">001509</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001509</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">COVID-19 and cardiac arrhythmias: a global perspective on arrhythmia characteristics and management strategies.</title><author><name sortKey="Gopinathannair, Rakesh" sort="Gopinathannair, Rakesh" uniqKey="Gopinathannair R" first="Rakesh" last="Gopinathannair">Rakesh Gopinathannair</name><affiliation><nlm:affiliation>The Kansas City Heart Rhythm Institute & Research Foundation, 5100 W 110th St, Ste 200, Overland Park, KS, 66211, USA. drrakeshg@yahoo.com.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>University of Missouri-Columbia, Columbia, USA. drrakeshg@yahoo.com.</nlm:affiliation></affiliation></author><author><name sortKey="Merchant, Faisal M" sort="Merchant, Faisal M" uniqKey="Merchant F" first="Faisal M" last="Merchant">Faisal M. Merchant</name><affiliation><nlm:affiliation>Emory University School of Medicine, Atlanta, GA, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Lakkireddy, Dhanunjaya R" sort="Lakkireddy, Dhanunjaya R" uniqKey="Lakkireddy D" first="Dhanunjaya R" last="Lakkireddy">Dhanunjaya R. Lakkireddy</name><affiliation><nlm:affiliation>The Kansas City Heart Rhythm Institute & Research Foundation, 5100 W 110th St, Ste 200, Overland Park, KS, 66211, USA.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>University of Missouri-Columbia, Columbia, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Etheridge, Susan P" sort="Etheridge, Susan P" uniqKey="Etheridge S" first="Susan P" last="Etheridge">Susan P. Etheridge</name><affiliation><nlm:affiliation>University of Utah, Salt Lake City, UT, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Feigofsky, Suzy" sort="Feigofsky, Suzy" uniqKey="Feigofsky S" first="Suzy" last="Feigofsky">Suzy Feigofsky</name><affiliation><nlm:affiliation>Iowa Heart Center, Des Moines, IA, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Han, Janet K" sort="Han, Janet K" uniqKey="Han J" first="Janet K" last="Han">Janet K. Han</name><affiliation><nlm:affiliation>Cardiac Arrhythmia Center, University of California at Los Angeles and VA Greater Los Healthcare Center, Los Angeles, CA, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Kabra, Rajesh" sort="Kabra, Rajesh" uniqKey="Kabra R" first="Rajesh" last="Kabra">Rajesh Kabra</name><affiliation><nlm:affiliation>University of Tennessee Health Science Center, Memphis, TN, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Natale, Andrea" sort="Natale, Andrea" uniqKey="Natale A" first="Andrea" last="Natale">Andrea Natale</name><affiliation><nlm:affiliation>Texas Cardiac Arrhythmia Institute, Austin, TX, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Poe, Stacy" sort="Poe, Stacy" uniqKey="Poe S" first="Stacy" last="Poe">Stacy Poe</name><affiliation><nlm:affiliation>Cleveland Clinic, Cleveland, OH, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Saha, Sandeep A" sort="Saha, Sandeep A" uniqKey="Saha S" first="Sandeep A" last="Saha">Sandeep A. Saha</name><affiliation><nlm:affiliation>Oregon Heart Center, Salem, OR, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Russo, Andrea M" sort="Russo, Andrea M" uniqKey="Russo A" first="Andrea M" last="Russo">Andrea M. Russo</name><affiliation><nlm:affiliation>Cooper University Hospital, Camden, NJ, USA.</nlm:affiliation></affiliation></author></analytic><series><title level="j">Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing</title><idno type="eISSN">1572-8595</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Anti-Arrhythmia Agents (administration & dosage)</term><term>Arrhythmias, Cardiac (diagnostic imaging)</term><term>Arrhythmias, Cardiac (drug therapy)</term><term>Arrhythmias, Cardiac (epidemiology)</term><term>COVID-19 (MeSH)</term><term>Coronavirus Infections (diagnosis)</term><term>Coronavirus Infections (drug therapy)</term><term>Coronavirus Infections (epidemiology)</term><term>Cross-Sectional Studies (MeSH)</term><term>Electrocardiography (methods)</term><term>Female (MeSH)</term><term>Humans (MeSH)</term><term>Incidence (MeSH)</term><term>Long QT Syndrome (diagnostic imaging)</term><term>Long QT Syndrome (drug therapy)</term><term>Long QT Syndrome (epidemiology)</term><term>Male (MeSH)</term><term>Pandemics (prevention & control)</term><term>Pandemics (statistics & numerical data)</term><term>Pneumonia, Viral (diagnosis)</term><term>Pneumonia, Viral (drug therapy)</term><term>Pneumonia, Viral (epidemiology)</term><term>Prognosis (MeSH)</term><term>Severity of Illness Index (MeSH)</term><term>Surveys and Questionnaires (MeSH)</term><term>Survival Rate (MeSH)</term><term>Torsades de Pointes (diagnostic imaging)</term><term>Torsades de Pointes (drug therapy)</term><term>Torsades de Pointes (epidemiology)</term><term>Treatment Outcome (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Anti-Arrhythmia Agents</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="diagnostic imaging" xml:lang="en"><term>Arrhythmias, Cardiac</term><term>Long QT Syndrome</term><term>Torsades de Pointes</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Arrhythmias, Cardiac</term><term>Coronavirus Infections</term><term>Long QT Syndrome</term><term>Pneumonia, Viral</term><term>Torsades de Pointes</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Arrhythmias, Cardiac</term><term>Coronavirus Infections</term><term>Long QT Syndrome</term><term>Pneumonia, Viral</term><term>Torsades de Pointes</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Electrocardiography</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Pandemics</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Pandemics</term></keywords><keywords scheme="MESH" xml:lang="en"><term>COVID-19</term><term>Cross-Sectional Studies</term><term>Female</term><term>Humans</term><term>Incidence</term><term>Male</term><term>Prognosis</term><term>Severity of Illness Index</term><term>Surveys and Questionnaires</term><term>Survival Rate</term><term>Treatment Outcome</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>BACKGROUND</b></p><p>Cardiovascular and arrhythmic events have been reported in hospitalized COVID-19 patients. However, arrhythmia manifestations and treatment strategies used in these patients have not been well-described. We sought to better understand the cardiac arrhythmic manifestations and treatment strategies in hospitalized COVID-19 patients through a worldwide cross-sectional survey.</p></div><div type="abstract" xml:lang="en"><p><b>METHODS</b></p><p>The Heart Rhythm Society (HRS) sent an online survey (via SurveyMonkey) to electrophysiology (EP) professionals (physicians, scientists, and allied professionals) across the globe. The survey was active from March 27 to April 13, 2020.</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS</b></p><p>A total of 1197 respondents completed the survey with 50% of respondents from outside the USA, representing 76 countries and 6 continents. Of respondents, 905 (76%) reported having COVID-19-positive patients in their hospital. Atrial fibrillation was the most commonly reported tachyarrhythmia whereas severe sinus bradycardia and complete heart block were the most common bradyarrhythmias. Ventricular tachycardia/ventricular fibrillation arrest and pulseless electrical activity were reported by 4.8% and 5.6% of respondents, respectively. There were 140 of 631 (22.2%) respondents who reported using anticoagulation therapy in all COVID-19-positive patients who did not otherwise have an indication. One hundred fifty-five of 498 (31%) reported regular use of hydroxychloroquine/chloroquine (HCQ) + azithromycin (AZM); concomitant use of AZM was more common in the USA. Sixty of 489 respondents (12.3%) reported having to discontinue therapy with HCQ + AZM due to significant QTc prolongation and 20 (4.1%) reported cases of Torsade de Pointes in patients on HCQ/chloroquine and AZM. Amiodarone was the most common antiarrhythmic drug used for ventricular arrhythmia management.</p></div><div type="abstract" xml:lang="en"><p><b>CONCLUSIONS</b></p><p>In this global survey of > 1100 EP professionals regarding hospitalized COVID-19 patients, a variety of arrhythmic manifestations were observed, ranging from benign to potentially life-threatening. Observed adverse events related to use of HCQ + AZM included prolonged QTc requiring drug discontinuation as well as Torsade de Pointes. Large prospective studies to better define arrhythmic manifestations as well as the safety of treatment strategies in COVID-19 patients are warranted.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32494896</PMID><DateCompleted><Year>2020</Year><Month>11</Month><Day>11</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1572-8595</ISSN><JournalIssue CitedMedium="Internet"><Volume>59</Volume><Issue>2</Issue><PubDate><Year>2020</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing</Title><ISOAbbreviation>J Interv Card Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>COVID-19 and cardiac arrhythmias: a global perspective on arrhythmia characteristics and management strategies.</ArticleTitle><Pagination><MedlinePgn>329-336</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10840-020-00789-9</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Cardiovascular and arrhythmic events have been reported in hospitalized COVID-19 patients. However, arrhythmia manifestations and treatment strategies used in these patients have not been well-described. We sought to better understand the cardiac arrhythmic manifestations and treatment strategies in hospitalized COVID-19 patients through a worldwide cross-sectional survey.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The Heart Rhythm Society (HRS) sent an online survey (via SurveyMonkey) to electrophysiology (EP) professionals (physicians, scientists, and allied professionals) across the globe. The survey was active from March 27 to April 13, 2020.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 1197 respondents completed the survey with 50% of respondents from outside the USA, representing 76 countries and 6 continents. Of respondents, 905 (76%) reported having COVID-19-positive patients in their hospital. Atrial fibrillation was the most commonly reported tachyarrhythmia whereas severe sinus bradycardia and complete heart block were the most common bradyarrhythmias. Ventricular tachycardia/ventricular fibrillation arrest and pulseless electrical activity were reported by 4.8% and 5.6% of respondents, respectively. There were 140 of 631 (22.2%) respondents who reported using anticoagulation therapy in all COVID-19-positive patients who did not otherwise have an indication. One hundred fifty-five of 498 (31%) reported regular use of hydroxychloroquine/chloroquine (HCQ) + azithromycin (AZM); concomitant use of AZM was more common in the USA. Sixty of 489 respondents (12.3%) reported having to discontinue therapy with HCQ + AZM due to significant QTc prolongation and 20 (4.1%) reported cases of Torsade de Pointes in patients on HCQ/chloroquine and AZM. Amiodarone was the most common antiarrhythmic drug used for ventricular arrhythmia management.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In this global survey of > 1100 EP professionals regarding hospitalized COVID-19 patients, a variety of arrhythmic manifestations were observed, ranging from benign to potentially life-threatening. Observed adverse events related to use of HCQ + AZM included prolonged QTc requiring drug discontinuation as well as Torsade de Pointes. Large prospective studies to better define arrhythmic manifestations as well as the safety of treatment strategies in COVID-19 patients are warranted.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gopinathannair</LastName><ForeName>Rakesh</ForeName><Initials>R</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-4611-3687</Identifier><AffiliationInfo><Affiliation>The Kansas City Heart Rhythm Institute & Research Foundation, 5100 W 110th St, Ste 200, Overland Park, KS, 66211, USA. drrakeshg@yahoo.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Missouri-Columbia, Columbia, USA. drrakeshg@yahoo.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Merchant</LastName><ForeName>Faisal M</ForeName><Initials>FM</Initials><AffiliationInfo><Affiliation>Emory University School of Medicine, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lakkireddy</LastName><ForeName>Dhanunjaya R</ForeName><Initials>DR</Initials><AffiliationInfo><Affiliation>The Kansas City Heart Rhythm Institute & Research Foundation, 5100 W 110th St, Ste 200, Overland Park, KS, 66211, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Missouri-Columbia, Columbia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Etheridge</LastName><ForeName>Susan P</ForeName><Initials>SP</Initials><AffiliationInfo><Affiliation>University of Utah, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feigofsky</LastName><ForeName>Suzy</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Iowa Heart Center, Des Moines, IA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Janet K</ForeName><Initials>JK</Initials><AffiliationInfo><Affiliation>Cardiac Arrhythmia Center, University of California at Los Angeles and VA Greater Los Healthcare Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kabra</LastName><ForeName>Rajesh</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>University of Tennessee Health Science Center, Memphis, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Natale</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Texas Cardiac Arrhythmia Institute, Austin, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poe</LastName><ForeName>Stacy</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Cleveland Clinic, Cleveland, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saha</LastName><ForeName>Sandeep A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Oregon Heart Center, Salem, OR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Russo</LastName><ForeName>Andrea M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Cooper University Hospital, Camden, NJ, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>06</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Interv Card Electrophysiol</MedlineTA><NlmUniqueID>9708966</NlmUniqueID><ISSNLinking>1383-875X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000889">Anti-Arrhythmia Agents</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Protocol" UI="C000705127">COVID-19 drug treatment</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000889" MajorTopicYN="N">Anti-Arrhythmia Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001145" MajorTopicYN="N">Arrhythmias, Cardiac</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004562" MajorTopicYN="N">Electrocardiography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008133" MajorTopicYN="N">Long QT Syndrome</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="Y">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016171" MajorTopicYN="N">Torsades de Pointes</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Arrhythmia</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Cardiac arrhythmia</Keyword><Keyword MajorTopicYN="N">QTc</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>05</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>05</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>6</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>11</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32494896</ArticleId><ArticleId IdType="doi">10.1007/s10840-020-00789-9</ArticleId><ArticleId IdType="pii">10.1007/s10840-020-00789-9</ArticleId><ArticleId IdType="pmc">PMC7268965</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nature. 2020 Mar;579(7798):270-273</Citation><ArticleIdList><ArticleId IdType="pubmed">32015507</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cardiovasc Electrophysiol. 2020 May;31(5):1003-1008</Citation><ArticleIdList><ArticleId IdType="pubmed">32270559</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2020 Jul 28;71(15):732-739</Citation><ArticleIdList><ArticleId IdType="pubmed">32150618</ArticleId></ArticleIdList></Reference><Reference><Citation>Biosci Trends. 2020 Mar 16;14(1):72-73</Citation><ArticleIdList><ArticleId IdType="pubmed">32074550</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2020 May 12;323(18):1775-1776</Citation><ArticleIdList><ArticleId IdType="pubmed">32203977</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2020 Jun;26(6):808-809</Citation><ArticleIdList><ArticleId IdType="pubmed">32488217</ArticleId></ArticleIdList></Reference><Reference><Citation>Chin Med J (Engl). 2020 May 5;133(9):1025-1031</Citation><ArticleIdList><ArticleId IdType="pubmed">32044814</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2020 Mar 17;323(11):1061-1069</Citation><ArticleIdList><ArticleId IdType="pubmed">32031570</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA Cardiol. 2020 Jul 1;5(7):811-818</Citation><ArticleIdList><ArticleId IdType="pubmed">32219356</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA Cardiol. 2020 Jul 1;5(7):802-810</Citation><ArticleIdList><ArticleId IdType="pubmed">32211816</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Mal Infect. 2020 Jun;50(4):384</Citation><ArticleIdList><ArticleId IdType="pubmed">32240719</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001509 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 001509 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidChloroV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= pubmed:32494896
|texte= COVID-19 and cardiac arrhythmias: a global perspective on arrhythmia characteristics and management strategies.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:32494896" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a CovidChloroV1
| This area was generated with Dilib version V0.6.38. |  |